PMID- 32275937 OWN - NLM STAT- MEDLINE DCOM- 20200601 LR - 20200601 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 252 DP - 2020 Jul 1 TI - Liraglutide protects pancreatic beta cells from endoplasmic reticulum stress by upregulating MANF to promote autophagy turnover. PG - 117648 LID - S0024-3205(20)30396-9 [pii] LID - 10.1016/j.lfs.2020.117648 [doi] AB - AIMS: This study was conducted to determine the relationship between mesencephalic astrocyte-derived neurotrophic factor (MANF), autophagy and endoplasmic reticulum (ER) stress, and whether liraglutide (LRG) can protect beta cells, promote autophagy and alleviate ER stress by regulating MANF expression. MAIN METHODS: Human serum samples were collected from healthy controls (NC), simple hyperlipidemia (HLD), and newly diagnosed type 2 diabetes (T2D). The MANF levels were detected using ELISA. In vitro, after the mouse islet MIN6 cells were treated with glucose (GLU), palmitate (PA), thapsigargin (TG), LRG, and chloroquine (CQ), cell proliferation was detected using cell counting kit-8 (CCK-8), apoptosis-related protein cleaved caspase 3 (C-cas-3), ER stress, and autophagy-related proteins were detected by Western blotting, MANF, insulin, and C-cas-3 proteins were detected via immunofluorescence. Subcellular structures and autophagosomes were examined using electron microscopy. KEY FINDINGS: Compared with the NC group, the MANF levels in the HLD and T2D groups increased significantly. After ER stress induced by GLU, PA, and TG, cell viability decreased, while MANF, c-cas3, ERS, and autophagy-related proteins increased, which was related to the concentration of GLU, PA, and TG. Compared with the BSA group, the number of mitochondria and autophagosomes in the PA group increased and the mitochondria were damaged. In the PA and TG plus CQ groups, the effect was further exaggerated. But after co-treatment with LRG, the effects of GLU, PA, and TG were attenuated. SIGNIFICANCE: LRG protects islet beta cells from ER stress by upregulating MANF to promote autophagy turnover. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Fu, Jili AU - Fu J AD - Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76, Linjiang Road, Yuzhong District, Chongqing 400010, China. FAU - Nchambi, Kija Malale AU - Nchambi KM AD - Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, 76, Linjiang Road, Yuzhong District, Chongqing 400010, China. FAU - Wu, Hao AU - Wu H AD - Department of Hepatobiliary surgery, The Second Affiliated Hospital of Chongqing Medical University, 76, Linjiang Road, Yuzhong District, Chongqing 400010, China. FAU - Luo, Xie AU - Luo X AD - Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76, Linjiang Road, Yuzhong District, Chongqing 400010, China. FAU - An, Xizhou AU - An X AD - Department of Hematology, The Children Hospital of Chongqing Medical University, Yuzhong District, Chongqing 400014, China. FAU - Liu, Dongfang AU - Liu D AD - Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76, Linjiang Road, Yuzhong District, Chongqing 400010, China. Electronic address: 300306@hospital.cqmu.edu.cn. LA - eng PT - Journal Article DEP - 20200408 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Hypoglycemic Agents) RN - 0 (MANF protein, human) RN - 0 (Nerve Growth Factors) RN - 839I73S42A (Liraglutide) SB - IM MH - Animals MH - Autophagy/*drug effects MH - Cell Survival/drug effects MH - Diabetes Mellitus, Type 2/drug therapy MH - Endoplasmic Reticulum Stress/*drug effects MH - Humans MH - Hyperlipidemias/drug therapy MH - Hypoglycemic Agents/pharmacology MH - Insulin-Secreting Cells/*drug effects/metabolism MH - Liraglutide/*pharmacology MH - Mice MH - Nerve Growth Factors/*genetics MH - Up-Regulation/drug effects OTO - NOTNLM OT - Autophagy OT - Endoplasmic reticulum stress OT - Liraglutide OT - MANF OT - beta cells COIS- Declaration of competing interest The authors declare that there are no conflicts of interest. EDAT- 2020/04/11 06:00 MHDA- 2020/06/02 06:00 CRDT- 2020/04/11 06:00 PHST- 2020/01/09 00:00 [received] PHST- 2020/03/31 00:00 [revised] PHST- 2020/04/05 00:00 [accepted] PHST- 2020/04/11 06:00 [pubmed] PHST- 2020/06/02 06:00 [medline] PHST- 2020/04/11 06:00 [entrez] AID - S0024-3205(20)30396-9 [pii] AID - 10.1016/j.lfs.2020.117648 [doi] PST - ppublish SO - Life Sci. 2020 Jul 1;252:117648. doi: 10.1016/j.lfs.2020.117648. Epub 2020 Apr 8.